Hansen, L.L., Jensen, L.L., Dimitrakakis, C., Michalas, S., Gilbert, F., Barber, H.R.K., Overgaard, J., Arzimanoglou, II.: Allelic imbalance in selected chromosomal regions in ovarian cancer. Cancer Genetics and Cytogenetics, 139:1-8 (2002).
Arzimanoglou, II., Hansen, L.L., Chong, C., Li, Z., Psaroudi, M.C., Dimitrakakis, C., Jacovina, A.T., Shevciwk, M., Reid, L., Hajjar, K.A., Vassilaros, S., Michalas, S., Gilbert, F., Chervenak, F.A., Barber, H.R.K.: Frequent LOH at hMLH1, a highly variable SNP in hMSH3, and negligible coding instability in ovarian cancer. Anticancer Res., 22:969-976, 2002.
Al-Kouatly, H.B., Chasen, S.T., Gilbert, F., Alhner, R., Alonso, L.M., Chervenak, F.: Correlation between rare chromosomal abnormalities and prenatal ultrasound findings. Am. J. Med. Genet., 107:197-200, 2002.
Gilbert, F.: Cystic Fibrosis carrier screening: steps in the development of a mutation panel. Genetic Testing, 5:223-228, 2001.
Gilbert, F.: Familial dysautonomia and the expansion of the Ashkenazi Jewish carrier screening panel. Genetic Testing, 5:83-86, 2001.
Gilbert, F.: Current status of hemochromatosis carrier screening. Genetic Testing, 4:229-231, 2000.
Gilbert, F.: Promises and pitfalls in carrier screening: lessons from the Ashkenazi Jewish model. Genetic Testing, 2:301-304, 1999.
Miller, D.G., Tiwari, R., Pathak, S., Hopwood, V., Gilbert, F., Hsu, T.C.: DNA repair and mutagen sensitivity in patients with triple primary cancers. Cancer Epidemiology, Biomarkers, and Prevention, 7:321-327, 1998.
Education
B.S.,
Massachusetts Institute of Technology,
1962
M.D.,
Albert Einstein College of Medicine of Yeshiva University,
1966
